Atypical antipsychotic

Vraylar (cariprazine) Withdrawal

Vraylar (cariprazine) has the most gradual discontinuation profile of any antipsychotic because its active metabolite has an extraordinarily long half-life (1-3 weeks). Withdrawal effects emerge over weeks rather than days.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~48-96 hours for cariprazine; ~1-3 weeks for active metabolite (one of the longest of any psychiatric medication).

Withdrawal timeline

Onset— 2-4 weeks

Very gradual onset due to extremely long metabolite half-life.

Peak— Weeks 4-12

Return of underlying symptoms typically emerges over a 1-3 month window.

Resolution— Variable

Depends on alternative treatment.

Common symptoms

  • Return of underlying condition
  • Anxiety

Less common

  • Sleep disturbance

Tapering guidance

  • A typical taper reduces by 1.5 mg every 2-4 weeks. The long half-life provides a built-in auto-taper.
  • Coordinate the taper with the prescribing psychiatrist.

Where ketamine therapy fits

Vraylar is compatible with at-home ketamine therapy. Continue Vraylar as prescribed during ketamine treatment unless the prescribing psychiatrist advises otherwise.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

Why is Vraylar withdrawal more gradual than other antipsychotics?

The active metabolite has a half-life of 1-3 weeks, far longer than any other antipsychotic. This produces a built-in auto-taper after the last dose.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.